| Primary |
| Acute Myocardial Infarction |
18.3% |
| Acute Coronary Syndrome |
17.5% |
| Coronary Arterial Stent Insertion |
11.7% |
| Myocardial Infarction |
9.2% |
| Stent Placement |
6.7% |
| Type 2 Diabetes Mellitus |
5.8% |
| Hypertension |
5.0% |
| Coronary Stent Placement |
3.3% |
| Thrombosis Prophylaxis |
3.3% |
| Anticoagulant Therapy |
2.5% |
| Antiplatelet Therapy |
2.5% |
| Coronary Artery Disease |
2.5% |
| Myocardial Ischaemia |
2.5% |
| Cardiovascular Disorder |
1.7% |
| Coronary Revascularisation |
1.7% |
| Electrocardiogram St Segment Elevation |
1.7% |
| Prophylaxis |
1.7% |
| Analgesic Therapy |
0.8% |
| Angiogram |
0.8% |
| Angioplasty |
0.8% |
|
| Dyspnoea |
15.4% |
| Syncope |
7.7% |
| Urticaria |
7.7% |
| Weight Decreased |
7.7% |
| Rash |
5.1% |
| Rectal Haemorrhage |
5.1% |
| Refusal Of Treatment By Patient |
5.1% |
| Renal Failure Acute |
5.1% |
| Rhabdomyolysis |
5.1% |
| Thrombocytopenia |
5.1% |
| Thrombosis In Device |
5.1% |
| Wheezing |
5.1% |
| Abdominal Pain Upper |
2.6% |
| Accidental Overdose |
2.6% |
| Acute Myocardial Infarction |
2.6% |
| Anaphylactic Reaction |
2.6% |
| Atrial Fibrillation |
2.6% |
| Blood Creatine Phosphokinase Increased |
2.6% |
| Bradycardia |
2.6% |
| Cardiac Arrest |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
27.9% |
| Myocardial Infarction |
17.2% |
| Acute Myocardial Infarction |
11.6% |
| Prophylaxis |
7.0% |
| Acute Coronary Syndrome |
6.1% |
| Platelet Count Increased |
3.5% |
| Myocardial Ischaemia |
3.2% |
| Hypertension |
2.9% |
| Pain |
2.9% |
| Coronary Artery Disease |
2.6% |
| Thrombosis Prophylaxis |
2.3% |
| Fibromyalgia |
2.0% |
| Gastrointestinal Disorder |
2.0% |
| Angina Pectoris |
1.7% |
| Angioplasty |
1.7% |
| Anticoagulant Therapy |
1.2% |
| Diabetes Mellitus |
1.2% |
| Lung Transplant |
1.2% |
| Antiplatelet Therapy |
0.9% |
| Constipation |
0.9% |
|
| Loss Of Consciousness |
16.4% |
| Syncope |
14.5% |
| Weight Decreased |
12.7% |
| Rectal Haemorrhage |
7.3% |
| Abdominal Pain Upper |
5.5% |
| Drug Interaction |
5.5% |
| Rash |
5.5% |
| Drug Resistance |
3.6% |
| Panic Attack |
3.6% |
| Rhabdomyolysis |
3.6% |
| Thrombosis In Device |
3.6% |
| Ventricular Tachycardia |
3.6% |
| Acute Myocardial Infarction |
1.8% |
| Angioedema |
1.8% |
| Atrial Fibrillation |
1.8% |
| Atrioventricular Block |
1.8% |
| Blood Creatine Phosphokinase Increased |
1.8% |
| Cardiac Arrest |
1.8% |
| Completed Suicide |
1.8% |
| Erythema |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.8% |
| Prophylaxis |
13.6% |
| Acute Myocardial Infarction |
9.2% |
| Colorectal Cancer Metastatic |
5.3% |
| Hypertension |
5.0% |
| Myocardial Infarction |
3.9% |
| Osteoporosis |
3.3% |
| Percutaneous Coronary Intervention |
2.8% |
| Acute Coronary Syndrome |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Thrombosis Prophylaxis |
1.9% |
| Cardiac Disorder |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Arthritis |
1.4% |
| Spinal Pain |
1.4% |
| Diabetes Mellitus |
1.1% |
| Non-hodgkin's Lymphoma |
1.1% |
| Pain |
1.1% |
| Rheumatoid Arthritis |
1.1% |
|
| Myocardial Infarction |
16.4% |
| Pain |
11.5% |
| Long Qt Syndrome |
9.8% |
| Myositis |
9.8% |
| Sneezing |
9.8% |
| Thrombosis In Device |
8.2% |
| Acute Myocardial Infarction |
4.9% |
| Cardiac Failure |
3.3% |
| Dental Care |
3.3% |
| Epistaxis |
3.3% |
| Hypersensitivity |
3.3% |
| Thrombocytopenia |
3.3% |
| Acute Coronary Syndrome |
1.6% |
| Adverse Drug Reaction |
1.6% |
| Anaemia |
1.6% |
| Arteriosclerosis Coronary Artery |
1.6% |
| Bone Disorder |
1.6% |
| Cardiac Arrest |
1.6% |
| Coronary Arterial Stent Insertion |
1.6% |
| Coronary Artery Occlusion |
1.6% |
|
| Interacting |
| Infarction |
40.0% |
| Product Used For Unknown Indication |
35.0% |
| Stent Placement |
20.0% |
| Computerised Tomogram |
5.0% |
|
| Lymphoma |
33.3% |
| Vomiting |
33.3% |
| Renal Failure Acute |
16.7% |
| Thrombocytopenia |
16.7% |
|
